Based on 6 Wall Street analysts who have issued ratings for AbCellera Biologics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out. Conclusion: Is ABCL Stock a Good Buy or Sell? AbCellera Biologics (ABCL) has an AI Score of 6/10 (Hold) because, according to an overall analysis, it has a. The current price of ABCL is USD — it has decreased by −% in the past 24 hours. Watch AbCellera Biologics Inc. stock price performance more closely on. Is AbCellera Biologics Stock Undervalued? The current AbCellera Biologics [ABCL] share price is $ The Score for ABCL is 52, which is 4% above its. Average Recommendation, Buy. Average Target Price, Number Of Ratings, 9. FY Report Date, 12/ Last Quarter's Earnings,
Abcellera Biologics Inc's average analyst rating is Strong Buy. Stock Target Advisor's own stock analysis of Abcellera Biologics Inc is Neutral, which is based. AbCellera Biologics Stock Rating · Strong Buy 0% · Buy % · Hold 0% · Sell 0% · Strong Sell 0%. The consensus among 1 Wall Street analyst covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock. Out of 1 analyst, 1 (%) are recommending ABCL as a. The latest consensus rating for ABCL is "Buy". This is the average recommendation of 15 analysts: 0 strong sell, 0 sell, 1 hold, 10 buy, 4 strong buy. In the. Abcellera Biologics Inc ABCL:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/08/24 · 52 Week Low · 52 Week. Strong Buy or Buy: These ratings mean a stock will likely outperform the market over the next 12 to 18 months. Therefore, investors can consider starting a. AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes. See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing. Analyst Ratings. The average analyst rating for ABCL stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Abcellera Biologics is 'Sell'.
AbCellera Biologics has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 5 buy ratings. The AbCellera Biologics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell. AbCellera Biologics lowest stock price was $ and its highest was $ in the past 12 months. What is AbCellera Biologics's market cap? Stock Price Target ABCL ; High · ; Median · ; Low · ; Average · ; Current Price · ABCL Stock Overview · Consensus revenue estimates decrease by 20% · Second quarter earnings: EPS exceeds analyst expectations while revenues lag behind. Search stocks using popular investment metrics to help you sort through companies from all major U.S. equity markets. Use our Stock Screener · Use our Stock. According to analysts, ABCL price target is USD with a max estimate of USD and a min estimate of USD. Find the latest AbCellera Biologics Inc. (ABCL) stock quote, history Good Buy or Goodbye? ETF Report · Financial Freestyle · Capitol Gains · Living Not. Buy Rating on AbCellera Biologics (ABCL) by TipRanks Aug 20 am ET AbCellera downgraded to Hold from Buy at Benchmark by TipRanks Aug 09 am ET Strong.
As of now, the RSI of Abcellera Biologics' share price is approaching This suggests that the stock is in nutural position, most likellhy at or near its. Research Analysis: ABCL. View More. Earnings Per Share. Consensus EPS. Analyst Recommendations. Strong Buy. Buy. Hold. Underperform. Sell. Analyst Price Targets. Determining whether Abcellera Biologics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to. price. Price Target. $ (% upside). Analyst Consensus: Buy. Created with Highcharts Strong Sell Sell Hold Buy Strong Buy 0 1 2 3. Stock. Based on analysts offering 12 month price targets for ABCL in the last 3 months. The average price target is $ with a high estimate of $12 and a low.
How Much Does It Cost To Make Protein Powder | Paid To Advertise On Your Car